As per DelveInsight’s assessment, the Global Balloon Catheters Market size was USD 4.60 billion in 2021 and growing at a CAGR of 8.78% during the forecast period (2023 to 2028); it is expected to reach USD 7.62 billion by 2028. Some of the key factors such as the rising prevalence of cardiovascular diseases as well as brain aneurysms, increasing incidence of cancers in the pelvic region affecting the urinary system in varying capacities, growing geriatric population base, and technical innovation in product development, among other factors, are expected to drive the balloon catheters market. The leading MedTech giants such as Medtronic, Boston Scientific Corporation, Abbott, Cook, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, Stryker, Teleflex Incorporated, Microport Scientific Corporation, BIOTRONIK, Nipro Medical Corporation, BD, Coloplast, Summit Medical (Innovia Medical) Well Lead Medical Co., Smiths Medical, BACTIGUARD AB, JOTEC GmbH, Lepu Medical Technology (Beijing) Co., Ltd, Merit Medical, Cardiovascular Systems Inc and others are actively working in the Global Balloon Catheters Market.
DelveInsight’s “Balloon Catheters Market Insight, Competitive Landscape and Market Forecast 2028” research report provides the current and forecasted Balloon Catheters market size, share, and trends analysis for the next five years. Moreover, it highlights the ongoing innovations in the segment, major market drivers & barriers, key competitors, and emerging devices in the domain.
Balloon Catheters Market: Overview
A balloon catheter is a type of soft catheter that has a balloon attached at the tip of the catheter. This type of catheter is used in various minimally invasive diagnostic and therapeutic procedures such as opening of blockages, dilating vessels, and stent delivery among others.
To provide a better understanding of the market dynamics, DelveInsight’s “Balloon Catheters Market” report provides an in-depth assessment of the market by product type (PTA, PTCA, occlusion, Foley, nephrostomy, drug-eluting, and others), by catheter type (fixed wire, over-the-wire, and rapid exchange), by balloon type (non-compliant, semi-compliant, and compliant), and by end-user (hospitals, specialty clinics, and others).
As per the analysis, in the balloon type segment of the balloon catheters market, the compliant balloon type category is estimated to account for a significant revenue share in the forecast period. Compliant balloons are capable of expanding in response to the increase in internal pressure. This property of compliant balloons makes them suitable for various applications such as expanding or occluding tissue or even holding the device in place, such as the Foley catheters.
The surging prevalence of cancers especially of the lower pelvis such as prostate, colon, rectal, and bladder among others are expected to immensely drive the balloon catheters market in the coming years. Cancers originating in the lower pelvis region often impact ureters as well, as cancerous growth may block the ureter and affect the flow of urine from the kidney to the bladder. Nephrostomy balloon catheters are deployed to create a passage for urine. Therefore, the demand for nephrostomy balloon catheters is said to witness an increase owing to the increasing prevalence of cancers, especially in the pelvic region, thereby driving the growth of the global balloon catheters market during the forecast period.
The increasing prevalence of cardiovascular diseases is another major factor immensely driving the Balloon Catheters Market growth. As per WHO, (2023), cardiovascular disease (CVD) is the leading cause of death worldwide, with an estimated 17.9 million deaths annually across the globe. Myocardial infarction, strokes, congestive heart failure, peripheral arterial disease, heart attacks, and acute coronary syndrome are some of the major types of Cardiovascular diseases. The majority of cardiovascular diseases are treated via procedures such as percutaneous transluminal coronary angioplasty (PTCA) where in PTCA balloon catheters are extensively employed. Thus, the increasing prevalence of cardiovascular diseases is expected to result in the conductance of a higher number of PCI procedures, which in turn would drive the demand for PTCA balloon catheters.
However, some of the key aspects such as the specific limitations associated with each type of balloon catheter, and probable procedural risks and product recalls may hamper the balloon catheter market growth.
Interested to know more about the ongoing developments in the market? Visit to get an in-depth insight @ Balloon Catheters Types and Emerging Products
Among all the regions, North America holds a significant market share in the balloon catheters market. North America is anticipated to dominate the global market in the upcoming years owing to the increasing prevalence of urological disorders, the rising prevalence of lifestyle disorders leading to the development of various cardiovascular diseases, and the intense growth in product development activities in the region.
Bladder and kidney cancer are two of the most common cancers in the United States. As per the estimate, the high prevalence of various types of cancer in the North American region is one of the prominent reasons for the widespread use of balloon catheters. In 2021, about 83,000+ new cases of bladder cancer were reported in the US. The rising prevalence of bladder cancer in the upcoming years will immensely drive the demand for balloon catheters, ultimately driving revenue growth in the North American balloon catheter market. Moreover, the rising prevalence of brain aneurysms in the country and the rising prevalence of cardiovascular disorders are other major factors contributing to the regional growth of the North American balloon catheter market.
Interested in knowing how the market will grow by 2028? Click to get a snapshot @ Balloon Catheters Market Trends and Developments
Over the years, the Balloon Catheters market has evolved significantly, owing to the active participation of the global MedTech companies and technological advancements in the domain. Similarly, several clinical, commercial, and regulatory developments have also been registered in the domain. Some of the major advancements in the Balloon Catheters market in recent years include –
- On the 25th of April 2023, US FDA granted the third IDE approval for Concept Medical’s Sirolimus Coated Balloon – MagicTouch SCB. Along with this latest IDE approval for the treatment of Small Vessel indication, Concept Medical received two other IDE approvals for the Magic Touch SCB family of products for the treatment of coronary In-Stent Restenosis (ISR) indication and Below-the-Knee indication (PTA).
- On May 27, 2022, Medtronic announced approval from the U.S. Food and Drug Administration (FDA) for the IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter, a drug-coated balloon (DCB), indicated for the interventional treatment of peripheral arterial disease (PAD) in the superficial femoral and popliteal arteries.
- In July 2021, Medtronic launched the newest-generation drug-coated balloon catheter ‘Prevail™’ for the treatment of coronary artery disease in Europe after the device was awarded the CE (Conformité Européene) mark.
- In June 2021, Neurescue received 510K clearance from the US Food and Drug Administration for their NEURESCUE® device, ‘the world’s first intelligent balloon catheter’, devised for the temporary occlusion of large vessels such as the aorta.
- In March 2021, Alvimedica received the CE mark approval for their Fluydo™ NC, a new PTCA NON-COMPLIANT Balloon Catheter. The device comprises a new Non-Compliant Balloon designed to dilate the hardest lesions located into the most difficult and challenging coronary lesions in an efficient manner.
Learn more about major clinical and commercial development in the market @ Balloon Catheters Market – Clinical and Commercial Development Activities
Globally, some of the leading MedTech giants working in the Balloon Catheters market include Medtronic, Boston Scientific Corporation, Abbott, Cook, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, Stryker, Teleflex Incorporated, Microport Scientific Corporation, BIOTRONIK, Nipro Medical Corporation, BD, Coloplast, Summit Medical (Innovia Medical) Well Lead Medical Co., Ltd, Smiths Medical, BACTIGUARD AB, JOTEC GmbH, Lepu Medical Technology (Beijing) Co., Ltd, Merit Medical, Cardiovascular Systems Inc and others. Owing to the rising demand and favorable growth opportunities for revenue generation, several new players are anticipated to enter the market, thereby leading to high competitiveness in the domain.
Learn how new players’ entries will transform the market dynamics in the coming years @ Balloon Catheters Competitive Landscape
Scope of the Balloon Catheters Market Report:
- Study Period – 2020-2028
- Geography Covered – North America, Europe, Asia-Pacific, and Rest of the World
- Balloon Catheters Market Assessment by –
- Product Type – PTA, PTCA, Occlusion, Foley, Nephrostomy, Drug-Eluting, and others
- Catheter Type – Fixed Wire, Over-The-Wire, and Rapid Exchange
- Balloon Type – Non-Compliant, Semi-Compliant, and Compliant
- Balloon Catheters Market by End User – Hospitals, Specialty Clinics, and others
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s Views
Table of Content
|3||Regulatory and Patent Analysis|
|4||Balloon Catheters Market Key Factors Analysis|
|5||Balloon Catheters Porter’s Five Forces Analysis|
|6||COVID-19 Impact Analysis on the Balloon Catheters Market|
|7||Balloon Catheters Market Layout|
|8||Balloon Catheters Global Company Share Analysis – Key 3–5 Companies|
|9||Balloon Catheters Product Profiles and Key Companies|
Reach out to us to get a more detailed overview of the market @ Balloon Catheters Market Insights, and Competitive Landscape
Other Trending Report by DelveInsight
Cellulitis Market | Cerebral Vein Thrombosis Market | Fibrocystic Breast Condition Market Idiopathic Membranous Nephropathy Market Mydriasis Market Artificial Iris Market Bronchopulmonary Dysplasia Market Chronic Gout Market Dermal Erythema Market Dysthymia Market Spinal Stenosis Market Wegener S Granulomatosis/granulomatosis With Polyangiitis Market Cipn Market Polycythemia Market Thyroid Eye Disease Market Age Related Vision Dysfunction Market Alpha-mannosidosis Market Bone Densitometers Market Binge Eating Disorder Market Beta Thalassemia Market Chronic Plaque Psoriasis Market Clostridium Difficile Infections Cdi Market Colorectal Cancer Crc Market Generalized Anxiety Disorder Market Trigeminal Neuralgia Market Size Atherectomy Devices Market Global Electrophysiology Devices Market Chronic Lymphocytic Leukemia Cll Market Defibrillators Market | Central Retinal Venous Occulsion Market | Chemotherapy-induced Peripheral Neuropathy Market | Epithelial Ovarian Cancer Market | Hearing Implants Market | Hearing Aid Devices Market | Neuromodulation Devices Market | Epilepsy Market | Lewy Body Dementia Market | Rett Syndrome Market | Anterior Cruciate Ligament Injuries Market | Nsclc Market | Optic Neuritis Market | Minimal Residual Disease Market | Encephalitis Market | Bone And Joint Infection Market | Bradycardia Treatment Devices Market | Bradykinesia Market | Non Alcoholic Fatty Liver Disease Nafld Market | Polypoidal Choroidal Vasculopathy Market | Primoridal Dwarfism Market | Adamantinoma Market | Anti-cd274 Pd-l1 Antibody Pipeline | Atypical Hemolytic Uremic Syndrome Ahus Market | Head And Neck Squamous Cell Carcinoma Market
Leverage the potential of consulting services to overcome the competition in the highly evolving and dynamic healthcare market with Healthcare Portfolio Management Services and Healthcare Partner Identification Services.
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Manager (Marketing & Branding)